# GeneDx Holdings Corp.: Form 8-K, filed Mar 2, 2026

- Company: [GeneDx Holdings Corp.](/companies/wgs.md) (CIK 1818331)
- Form: 8-K
- Filed: 2026-03-02
- Accepted by EDGAR: Mar 2, 2026, 07:02 ET
- Period: 2026-02-27
- Accession: 0001818331-26-000021
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1818331/000181833126000021/wgs-20260227.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1818331/000181833126000021/

## Items reported

- Item 1.01: Entry into a material agreement
- Item 1.02: Termination of a material agreement
- Item 2.03: New direct financial obligation

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1818331/000181833126000021/wgs-20260227.htm

Filed Mar 2, 2026.
Source: SEC EDGAR, the filing index for accession 0001818331-26-000021. Last ingested by Listed: Nov 14, 2026, 12:59 ET. No prices; not investment advice.
